Mitochondrial Transplantation Therapy Ameliorates Muscular Dystrophy in <i>mdx</i> Mouse Model
Duchenne muscular dystrophy is caused by loss of the dystrophin protein. This pathology is accompanied by mitochondrial dysfunction contributing to muscle fiber instability. It is known that mitochondria-targeted in vivo therapy mitigates pathology and improves the quality of life of model animals....
| Published in: | Biomolecules |
|---|---|
| Main Authors: | , , , , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-03-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/2218-273X/14/3/316 |
